SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001168220-17-000005
Filing Date
2017-03-01
Accepted
2017-03-01 17:11:46
Documents
8
Period of Report
2017-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K MARCH 1, 2017 form8k_030117.htm 8-K 53103
2 NOTE, WARRANT AND PREFERRED STOCK PURCHASE AGREEMENT ex_10-1.htm EX-10.1 415102
3 SECURED CONVERTIBLE PROMISSORY NOTE ex_10-2.htm EX-10.2 73960
4 SECURITY AGREEMENT ex_10-3.htm EX-10.3 95439
5 VOTING AGREEMENT ex_10-4.htm EX-10.4 111579
6 INVESTOR AGREEMENT ex_10-5.htm EX-10.5 151319
7 BACKSTOP AGREEMENT ex_10-6.htm EX-10.6 125738
8 PRESS RELEASE, DATED FEBRUARY 28, 2017 ex_99-1.htm EX-99.1 14120
  Complete submission text file 0001168220-17-000005.txt   1042012
Mailing Address 4452 BELTWAY DRIVE ADDISON TX 75001
Business Address 4452 BELTWAY DRIVE ADDISON TX 75001 214-905-5145
ULURU Inc. (Filer) CIK: 0001168220 (see all company filings)

IRS No.: 412118656 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33618 | Film No.: 17655382
SIC: 2834 Pharmaceutical Preparations